April 16, 2018 / 5:52 AM / in 7 months

BRIEF-Adocia Starts First-In-Human Clinical Study Of BioChaperone Pramlintide Insulin

April 16 (Reuters) - ADOCIA SA:

* ADOCIA INITIATES FIRST-IN-HUMAN CLINICAL STUDY OF BIOCHAPERONE® PRAMLINTIDE INSULIN IN PEOPLE WITH TYPE 1 DIABETES

* STUDY IS EXPECTED TO BE COMPLETED IN Q3 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below